rs33930385
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM5PP3
The NM_000518.5(HBB):c.250G>T(p.Gly84Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G84D) has been classified as Likely benign.
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251436Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135888
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461874Hom.: 0 Cov.: 36 AF XY: 0.00000138 AC XY: 1AN XY: 727240
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
The Hb Ta-Li variant (HBB: c.250G>T; p.Gly84Cys, also known as Gly83Cys when numbered from the mature protein, rs33930385, HbVar ID: 410) is reported in the literature in several related individuals with no apparent anemia (Blackwell 1971, HbVar database). This variant is only observed on one allele in the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.612). A heat stability assay suggests it may be mildly unstable (Blackwell 1971). Further, biochemical characterization indicates that the variant protein oligomerizes through formation of intermolecular disulfide bonds (Fablet 2003, Rai 2002), although these oligomers display normal binding kinetics to carbon monoxide (Fablet 2003). However, as the full functional and clinical effects of this variant have not been characterized, the clinical significance of the p.Gly84Cys variant is uncertain at this time. References: HbVar database: https://globin.bx.psu.edu/hbvar/menu.html Blackwell RQ et al. Hemoglobin Ta-Li: 83 Gly leads to Cys. Biochim Biophys Acta. 1971 Sep 28;243(3):467-74. PMID: 5129589. Fablet C et al. Stable octameric structure of recombinant hemoglobin alpha(2)beta(2)83 Gly-->Cys. Protein Sci. 2003 Apr;12(4):690-5. PMID: 12649426. Rai DK et al. Characterization of the elusive disulfide bridge forming human Hb variant: Hb Ta-Li beta83 (EF7)Gly --> Cys by electrospray mass spectrometry. J Am Soc Mass Spectrom. 2002 Feb;13(2):187-91. PMID: 11838022. -
HEMOGLOBIN TA-LI Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at